A comprehensive multimodal pain treatment reduces opioid consumption after multilevel spine surgery

Eur Spine J. 2013 Sep;22(9):2089-96. doi: 10.1007/s00586-013-2826-1. Epub 2013 May 17.

Abstract

Purpose: Major spine surgery with multilevel instrumentation is followed by large amount of opioid consumption, significant pain and difficult mobilization in a population of predominantly chronic pain patients. This case-control study investigated if a standardized comprehensive pain and postoperative nausea and vomiting (PONV) treatment protocol would improve pain treatment in this population.

Methods: A new regimen with acetaminophen, NSAIDs, gabapentin, S-ketamine, dexamethasone, ondansetron and epidural local anesthetic infusion or patient controlled analgesia with morphine, was introduced in a post-intervention group of 41 consecutive patients undergoing multilevel (median 10) instrumented spinal fusions and compared with 44 patients in a pre-intervention group.

Results: Compared to patients in the pre-intervention group, patients treated according to the new protocol consumed less opioid on postoperative day (POD) 1 (P = 0.024) and 2 (P = 0.048), they were mobilized earlier from bed (P = 0.003) and ambulation was earlier both with and without a walking frame (P = 0.027 and P = 0.027, respectively). Finally, patients following the new protocol experienced low intensities of nausea, sedation and dizziness on POD 1-6.

Conclusions: In this study of patients scheduled for multilevel spine surgery, it was demonstrated that compared to a historic group of patients receiving usual care, a comprehensive and standardized multimodal pain and PONV protocol significantly reduced opioid consumption, improved postoperative mobilization and presented concomitant low levels of nausea, sedation and dizziness.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / administration & dosage
  • Acetaminophen / adverse effects
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amines / administration & dosage
  • Amines / adverse effects
  • Analgesics, Non-Narcotic / administration & dosage*
  • Analgesics, Non-Narcotic / adverse effects
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / adverse effects
  • Antiemetics / administration & dosage
  • Antiemetics / adverse effects
  • Case-Control Studies
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / adverse effects
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Drug Therapy, Combination
  • Female
  • Gabapentin
  • Humans
  • Male
  • Middle Aged
  • Pain, Postoperative / drug therapy*
  • Postoperative Nausea and Vomiting / chemically induced
  • Postoperative Nausea and Vomiting / drug therapy
  • Spinal Diseases / surgery*
  • Spinal Fusion / adverse effects*
  • Young Adult
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / adverse effects

Substances

  • Amines
  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Antiemetics
  • Cyclohexanecarboxylic Acids
  • Acetaminophen
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Dexamethasone